🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Henry H. Hsu

Bellevue College

ORCID: 0009-0002-8018-2651

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT”.

Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-2007

N/A

0.965DataRank · unranked

32 citations

Arun S. Singh, Stephen P. Anthony, Mike Sterba, Chao Zhang, John H. Healey +19 more

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae202

N/A

0.345DataRank · unranked

9 citations

Adam L. Cohen, Midori Eckenstein, Randy L. Jensen, Lindsay Burt, Karen L. Salzman +18 more

Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

Cancer(2020)10.1002/cncr.33312

N/A

0DataRank · unranked

70 citations

Andrew J. Wagner, William D. Tap, Emanuela Palmerini, Zev A. Wainberg, Jayesh Desai +11 more

Recurrent Mutations in Cyclin D3 Confer Clinical Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3458

N/A

0DataRank · unranked

16 citations

Aaron D. Viny, Evan Massi, Cyriac Kandoth, Nicholas D. Socci, Franck Rapaport +12 more